We have lived through an extraordinary year for the biopharmaceutical industry. Given excellent protection data on two COVID-19 vaccines we now appear to be at the beginning of the end of the COVID-19 pandemic. A “return to normalcy” appears possible in 2021 despite a very challenging situation at present with the pandemic.
1、Given the exceptional performance of the biopharma market in 2020, what does 2021 hold?
2、It appears likely that with widespread vaccination, the COVID-19 pandemic will recede in 2021.What does this imply for the biopharma sector?
3、What are the implications of the U.S. political situation for the global biopharmaceutical sector?
相关推荐
热门下载
推荐
快速链接
热门标签
关注我们
扫码关注我们
了解更多相关信息